Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Alisporivir> ?p ?o. }
Showing items 1 to 46 of
46
with 100 items per page.
- Alisporivir abstract "Alisporivir (INN), or Debio 025, DEB025, (or UNIL-025) is a cyclophilin inhibitor. Its structure is reminiscent of, and synthesized from ciclosporin.It inhibits cyclophilin A. Alisporivir is not immunosuppressive.It is being researched for potential use in the treatment of hepatitis C. It has also been investigated for Duchenne muscular dystrophy.Alisporivir is under development by Debiopharm for Japan and by Novartis for the rest of the world (licence granted by Debiopharm) since February 2010.".
- Alisporivir atcPrefix "None".
- Alisporivir casNumber "254435-95-5".
- Alisporivir pubchem "11513676".
- Alisporivir thumbnail Alisporivir.svg?width=300.
- Alisporivir wikiPageID "21633417".
- Alisporivir wikiPageRevisionID "590543418".
- Alisporivir atcPrefix "None".
- Alisporivir c "63".
- Alisporivir casNumber "254435".
- Alisporivir chembl "1651956".
- Alisporivir chemspiderid "9688467".
- Alisporivir h "113".
- Alisporivir hasPhotoCollection Alisporivir.
- Alisporivir inchi "1".
- Alisporivir inchikey "OLROWHGDTNFZBH-XEMWPYQTBH".
- Alisporivir kegg "D10087".
- Alisporivir molecularWeight "1216.64".
- Alisporivir n "11".
- Alisporivir niaidChemdb "268533".
- Alisporivir o "12".
- Alisporivir pubchem "11513676".
- Alisporivir smiles "O=C1N[C@H]CC".
- Alisporivir stdinchi "1".
- Alisporivir stdinchikey "OLROWHGDTNFZBH-XEMWPYQTSA-N".
- Alisporivir verifiedfields "changed".
- Alisporivir verifiedrevid "453501641".
- Alisporivir subject Category:Drugs.
- Alisporivir type Agent114778436.
- Alisporivir type CausalAgent100007347.
- Alisporivir type Drug103247620.
- Alisporivir type Drugs.
- Alisporivir type Matter100020827.
- Alisporivir type PhysicalEntity100001930.
- Alisporivir type Substance100020090.
- Alisporivir type Drug.
- Alisporivir type FunctionalSubstance.
- Alisporivir comment "Alisporivir (INN), or Debio 025, DEB025, (or UNIL-025) is a cyclophilin inhibitor. Its structure is reminiscent of, and synthesized from ciclosporin.It inhibits cyclophilin A. Alisporivir is not immunosuppressive.It is being researched for potential use in the treatment of hepatitis C. It has also been investigated for Duchenne muscular dystrophy.Alisporivir is under development by Debiopharm for Japan and by Novartis for the rest of the world (licence granted by Debiopharm) since February 2010.".
- Alisporivir label "Alisporivir".
- Alisporivir sameAs m.05mqkr9.
- Alisporivir sameAs Q4727236.
- Alisporivir sameAs Q4727236.
- Alisporivir sameAs Alisporivir.
- Alisporivir wasDerivedFrom Alisporivir?oldid=590543418.
- Alisporivir depiction Alisporivir.svg.
- Alisporivir isPrimaryTopicOf Alisporivir.
